Bausch Health Companies | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Amgen USD 1.69B 191M 2025-03
ANI Pharmaceuticals USD 81.77M 5.24M 2025-06
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bausch Health Companies USD 894M 27M 2025-06
Biogen USD 583.8M 11.3M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 103.85M 13.19M 2025-06
Danaher USD 2.36B 502M 2025-06
Drreddys Laboratories INR 21.59B 436M 2024-12
Eli Lilly USD 2.75B 390.8M 2025-06
Gilead Sciences USD 1.36B 100M 2025-06
Novo Nordisk 18.85B 2.74B 2025-06
Pacira USD 77.19M 9.58M 2025-06
Perrigo USD 273.1M 8.1M 2025-06
Prestige Brands USD 28.46M 35.6M 2025-06
Supernus Pharmaceuticals USD 62.22M 27.72M 2025-06
Vertex Pharmaceuticals USD 424.6M 28.2M 2025-06
Zoetis USD 617M 54M 2025-06


Bausch Health Companies Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.